SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001682852-24-000046
Filing Date
2024-08-01
Accepted
2024-08-01 16:02:28
Documents
88
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrna-20240630.htm   iXBRL 10-Q 1384637
2 EX-31.1 exhibit3116302024.htm EX-31.1 9147
3 EX-31.2 exhibit3126302024.htm EX-31.2 9092
4 EX-32.1 exhibit3216302024.htm EX-32.1 8224
10 mrna-20240630_g1.jpg GRAPHIC 63925
11 mrna-20240630_g2.jpg GRAPHIC 678991
  Complete submission text file 0001682852-24-000046.txt   9871388

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrna-20240630.xsd EX-101.SCH 52101
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrna-20240630_cal.xml EX-101.CAL 107456
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrna-20240630_def.xml EX-101.DEF 192282
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrna-20240630_lab.xml EX-101.LAB 635910
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrna-20240630_pre.xml EX-101.PRE 451849
91 EXTRACTED XBRL INSTANCE DOCUMENT mrna-20240630_htm.xml XML 1444551
Mailing Address 325 BINNEY STREET CAMBRIDGE MA 02142
Business Address 325 BINNEY STREET CAMBRIDGE MA 02142 6177146500
Moderna, Inc. (Filer) CIK: 0001682852 (see all company filings)

IRS No.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38753 | Film No.: 241166455
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)